By Kashish Tandon (Reuters) -Indian drugmaker Anthem Biosciences' [ANTH.NS] $395 million IPO was fully subscribed on the ...

Sunaina Sinha Haldea, Raymond James Head of Private Capital Advisory, joins 'Closing Bell Overtime' to talk the state of the ...

Shares of NTT DC REIT , a data centre real estate investment trust, were steady in its first full trading session on Tuesday, ...

UNITED States publisher McGraw Hill is targeting a valuation of $4.2 billion in its initial public offering (IPO), the company said on Monday, joining other private equity-backed firms looking to take ...

The Monika Alcobev IPO is a combination of fresh issue of 47.91 lakh shares, and an offer-for-sale of 10 lakh shares by two ...

Property Share Investment Trust announces Rs 473 crore IPO for its second SM REIT scheme, PropShare Titania, opening July 21.

According to market observers, shares of the company are available at a premium of ₹101 in the grey market today ...

The public issue will open for subscription on July 21 and close on July 23, while the anchor book for institutional ...

Industrial laminates manufacturer Lamtuf files draft IPO papers with Sebi to raise funds through an initial public offering ...

The Bengaluru-headquartered co-working firm, which submitted its Draft Red Herring Prospectus (DRHP) earlier in February, was ...

Carlsmed, a spine surgery solution company, announced today that it launched its initial public offering with the start of an ...

Anthem Biosciences' initial share sale received bids for 14,47,66,596 shares, as against 4,40,70,682 shares on offer, ...